SRE
37
9
CMI
49
2
EBAY
42
2
UA
48
6
OI
23
3
CSCO
63
5
GS
65
16
HAS
29
3
DOW
47
4
WHR
61
3
ILMN
31
4
GE
60
5
GD
42
4
VIX
41
-11
HPE
48
2
GWW
50
9
CTSH
55
3
ZION
49
9
JNJ
30
4
TSCO
42
4
SRE
37
9
CMI
49
2
EBAY
42
2
UA
48
6
OI
23
3
CSCO
63
5
GS
65
16
HAS
29
3
DOW
47
4
WHR
61
3
ILMN
31
4
GE
60
5
GD
42
4
VIX
41
-11
HPE
48
2
GWW
50
9
CTSH
55
3
ZION
49
9
JNJ
30
4
TSCO
42
4
Financhill
Back

Repligen Stock Predictions

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
49

RGEN
Repligen

Last Price:
$145.60
Seasonality Move:
20.07%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Repligen Stock Forecast

  • Over the next 52 weeks, Repligen has on average historically risen by 18.3% based on the past 38 years of stock performance.
  • Repligen has risen higher in 22 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
  • Is Repligen Stock Undervalued?
    The current Repligen [RGEN] share price is $144.47. The Score for RGEN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Repligen Stock Go Up Next Year?

  • Over the next 52 weeks, Repligen has on average historically risen by 18.3% based on the past 38 years of stock performance.

Repligen Stock Rating

Sell
49
Repligen (RGEN) is a Sell

Is Repligen overpriced?

  • Repligen has risen higher in 22 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%

Repligen Stock Price History

Is RGEN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com

52-Week Data

52-Week High:
211.13
52-Week Low:
113.50

Prediction Charts

Market Cap:
8.1B
Price in USD:
144.47
Volume:
1.4M
Beta:
0.97

Technical Analysis

SMA50:
143.82
SMA100:
146.37
SMA200:
151.49
52-Wk Change:
-19.66%

Stock Predictions

  • Is Repligen stock public?
    Yes, Repligen is a publicly traded company.
  • What is the Repligen stock quote today?
    The Repligen stock price is 144.47 USD today.
  • How to buy Repligen stock online?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 148.64 148.50 149.81 145.97
Dec-4 148.50 149.09 150.78 145.97
Dec-5 147.87 142.26 148.17 142.15
Dec-6 143.78 149.20 150.56 143.24
Dec-9 150.35 154.72 156.94 149.97
Dec-10 154.71 151.94 156.75 150.56
Dec-11 153.54 155.25 157.25 152.34
Dec-12 153.13 155.99 157.91 153.13
Dec-13 156.54 156.41 158.07 151.50
Dec-16 155.37 160.92 161.24 155.37
Dec-17 159.94 158.14 160.65 157.24
Dec-18 158.23 147.34 160.05 146.45
Dec-19 147.26 146.54 149.32 143.91
Dec-20 145.70 144.47 150.56 143.96

Repligen Earnings

Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.

Repligen Forecast Revenue Growth

Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.19 per share.

* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.